ArticleCancer chemotherapy and pharmacology2016

A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.

Analía Azaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.